Received Jul 8, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
He has not yet had the second dose which was due between 24 Dec 2024 and 24 Apr 2025, but will receive it today; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in a 60-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (On 24-OCT-2024, the patient received 1st dose). On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: He has not yet had the second dose which was due between 24 Dec 2024 and 24 Apr 2025, but will receive it today). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 03-JUL-2025 This report was submitted via the online direct entry reporting system. The Pharmacy technician reported that the patient received his first dose on 24 Oct 2024. The patient not yet had the second dose which was due between 24-Dec-2024 and 24-Apr-2025 but would receive it on the day of reporting. Till the time of reporting the patients did not receive the second dose of Shingrix, which led to incomplete course of vaccination.